Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cisplatin resistance in gastric cancer cells is involved with GPR30‐mediated epithelial‐mesenchymal transition
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-13
DOI
10.1111/jcmm.15055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition
- (2018) Liang-Qing Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer
- (2018) Dong-Mei Wu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Activation of GPR30 stimulates GTP-binding of Gαi1 protein to sustain activation of Erk1/2 in inhibition of prostate cancer cell growth and modulates metastatic properties
- (2017) Kin-Mang Lau et al. EXPERIMENTAL CELL RESEARCH
- GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer
- (2017) Luis Molina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer
- (2017) Jiahui Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The role of GLI2 - ABCG2 signaling axis for 5Fu resistance in gastric cancer
- (2017) Beiqin Yu et al. Journal of Genetics and Genomics
- Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Daniel V T Catenacci et al. LANCET ONCOLOGY
- Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer
- (2017) Kinro Sasaki et al. MEDICAL ONCOLOGY
- The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
- (2017) Pingting Zhou et al. Molecular Cancer
- G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer
- (2017) Changyu Liu et al. ONCOLOGY RESEARCH
- The clinicopathologic significance of estrogen receptors in human gastric carcinoma
- (2016) M. Wesołowska et al. BIOMEDICINE & PHARMACOTHERAPY
- GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts
- (2016) Assunta Pisano et al. MOLECULAR CARCINOGENESIS
- Anti-Cancer Activity of Solanum nigrum (AESN) through Suppression of Mitochondrial Function and Epithelial-Mesenchymal Transition (EMT) in Breast Cancer Cells
- (2016) Ying-Jang Lai et al. MOLECULES
- Estrogen receptors in gastric cancer: Advances and perspectives
- (2016) Muhammad Saif Ur Rahman WORLD JOURNAL OF GASTROENTEROLOGY
- Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
- (2016) A. Marcell Szász et al. Oncotarget
- Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism
- (2015) Helena Joyce et al. Expert Opinion on Drug Metabolism & Toxicology
- G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1
- (2015) Changyu Liu et al. MEDICAL ONCOLOGY
- Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer
- (2015) S-Q Liang et al. Cell Death & Disease
- Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells
- (2014) Paulina Grygielewicz et al. Gastric Cancer
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells
- (2014) Jian Qin et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell–matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis
- (2014) Yan Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Management of gastric cancer in Asia: resource-stratified guidelines
- (2013) Lin Shen et al. LANCET ONCOLOGY
- Testican-1-mediated epithelial–mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer
- (2013) H-P Kim et al. ONCOGENE
- The G-protein-coupled estrogen receptor GPER in health and disease
- (2011) Eric R. Prossnitz et al. Nature Reviews Endocrinology
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started